A prospective study of the hearing disorder in the patient receiving cisplati
Not Applicable
- Conditions
- Malignant tumor
- Registration Number
- JPRN-UMIN000017989
- Lead Sponsor
- Kobe minimally invasive cancer center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient that periodical audiometry is impossible 2) Patient younger than 20 years 3) The patient who judged a study doctor to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of hearing disorder more than CTCAE Grade2
- Secondary Outcome Measures
Name Time Method Toxicity, dose intensity of cisplatin, change of the mean hearing threshold level